Search results
Author(s):
Andrew Goldsweig
Added:
5 months ago
What are the main management recommendations from SCAI and HRS concerning left atrial appendage occlusion?In this short interview, Dr Andrew Goldsweig (Baystate Medical Center, Springfield, US) discusses the new guidelines regarding transcatheter left atrial appendage occlusion by the Society for Cardiovascular Angiography & Interventions and Heart Rhythm Society. The multidisciplinary guideline…
View more
Author(s):
Riccardo Cappato
,
Rui Providencia
Added:
11 months ago
What updates do ECAS recommend for catheter ablation of atrial fibrillation?In this short interview, Prof Riccardo Cappato (IRCCS Humanitas Research Hospital, Milan, IT) and Prof Rui Providência (St Bartholomew's Hospital, London, UK) discuss new guidelines released by ECAS on catheter ablation for atrial fibrillation (AF). Prof Cappato and Prof Providência explain the need for an updated and…
View more
Author(s):
Kenneth Ellenbogen
Added:
1 year ago
A new policy statement released by HRS underscores the importance of continual training and education for electrophysiologists performing catheter ablation of atrial fibrillation (AF).In this short interview, Dr Kenneth Ellenbogen (VCU School of Medicine, US) discusses the key recommendations within this policy statement to ensure a strong electrophysiology base and skillset to achieve the best…
View more
Author(s):
Roland R Tilz
Added:
3 weeks ago
AF Symposium 2026 - Prof Roland Tilz (University Heart Center Lübeck, DE) discusses an innovative awake workflow for atrial fibrillation ablation using pulsed field ablation technology with the Volt balloon-in-basket system, eliminating the need for propofol-based deep sedation.Patient experience data revealed nuanced outcomes: while intraprocedural pain scores averaged 7/10 during energy…
View more
Author(s):
Jose A Joglar
Added:
2 years ago
Dr Jose Joglar (UT Southwestern, US) joins us virtually to discuss the 2023 guidelines for atrial fibrillation (AF) diagnosis and management.These guidelines are an update to the 2014 document covering the full spectrum of managing patients with AF, from prevention to lifetime interventions, to rhythm and rate control, as well as special populations. A new classification of AF has been created,…
View more
Author(s):
Vivek Reddy
Added:
3 weeks ago
AF Symposium 2026 - Dr Vivek Reddy (Icahn School of Medicine at Mount Sinai, New York, NY, US) joins us to discuss findings from the ADVENT LTO study, evaluating long-term outcomes and atrial fibrillation progression in patients who received ablation with the FARAPULSE Pulsed Field Ablation System compared to thermal ablation.The study tracked AF progression patterns, arrhythmia recurrence rates,…
View more
Author(s):
Marat Fudim
,
David Duncker
Added:
3 weeks ago
In this episode of Arrhythmia Academy's Journal Club, Dr David Duncker (Hannover Heart Rhythm Center, DE) is joined by Dr Marat Fudim (Duke University, US) to examine the critical early-risk period following heart failure diagnosis and the emerging role of wearable cardioverter defibrillators in sudden cardiac death prevention.The discussion centres on findings from the SCD-PROTECT study, a 19…
View more
Patient Selection for Leadless Pacemakers
Video Series
Added:
5 months ago
Source:
Radcliffe Cardiology
AUTHOR: Jordan RanceRisk stratification for primary prevention implantable cardioverter-defibrillator (ICD) placement in patients with cardiac sarcoidosis remains a clinical challenge, partly due to inconsistencies in diagnostic criteria and the variable course of the disease. A new study published in the European Heart Journal suggests that cardiovascular magnetic resonance (CMR) phenotyping has…
View more
Author(s):
Rahul Aggarwal
,
Dirk Müller-Wieland
Added:
5 months ago
Filmed onsite at EASD 2025, this on-demand series features key insights from Prof Dirk Müller-Wieland and Dr Rahul Aggarwal to interpret the latest data on eicosapentaenoic acid(EPA), including the latest sub-analysis of the REDUCE-IT trial, whichanalysed the effectiveness of icosapent ethyl (IPE) on CV risk by triglyceride-glucose (TyG) index - an indicator of insulin resistance and risk of type…
View more